ONCOLife Articles
Ferroptosis as a New Strategy: Iron-Driven Cell Death Targets Cancer Stem Cells
ONCOLife | 17 August 2025
Redesigned CD40 Antibody Triggers Systemic Tumor Regression and Complete Remission
ONCOLife | 15 August 2025
RNA Isoform RUNX1C Identified as Molecular “Switch” Behind Chemoresistance in Blood Cancer
ONCOLife | 16 August 2025
Bacteria Cloak Viruses to Safely Deliver Cancer-Killing Payloads into Solid Tumors
ONCOLife | 16 August 2025
mRNA Vaccines Plus Checkpoint Inhibitors Shows Curative Potential in Gastric Cancer
ONCOLife | 15 August 2025
PADCEV–KEYTRUDA Combination Delivers Survival Gains in High-Risk Bladder Cancer
ONCOLife | 12 August 2025
Genetic Testing Boosts Safety, Reduces Chemotherapy Side Effects in GI Cancer
ONCOLife | 9 August 2025
Epcoritamab + R2 Achieves 95.7% ORR, Cuts Risk by 79% in R/R Follicular Lymphoma
ONCOLife | 8 August 2025
Targeting eIF2A to Halt Melanoma: Study Reveals Key Driver of Cancer Cell Migration
ONCOLife
2 August 2025
New Radioimmunotherapy Strategy Eradicates Cancer Stem Cells in Ovarian Cancer
ONCOLife
1 August 2025
Dr. Iris Kuss: ARANOTE Trial Results Signal a New Era in Prostate Cancer Treatment
ONCOLife
1 August 2025
Global Data Warns of Secondary Cancers Linked to CAR-T Therapy, Urging Monitoring
ONCOLife
31 July 2025
Artificial Sweetener Sucralose May Undermine Cancer Immunotherapy, Study Finds
ONCOLife
31 July 2025
First Non-Invasive Endometrial Cancer Detection Test, EdenDx, Launched by Gnosis
ONCOLife
31 July 2025
Supercharging Chemotherapy with a Mitochondrial Strategy for Lung Cancer Treatment
ONCOLife
30 July 2025
A Mitochondrial Makeover: Rewiring T Cells to Supercharge Cancer Immunotherapy
ONCOLife
29 July 2025
Imfinzi Receives FDA Priority Review as First Immunotherapy for Gastric and GEJ Cancers
FDA & EMA
28 July 2025
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.
